Predictors of Long Term Outcomes in 11,441 Consecutive Patients Following Percutaneous Coronary Interventions

American Journal of Cardiology

Volumn 115, Issue 7, 2015, Pages 855-859

  Landes, Uri ^a,b   Kornowski, Ran ^a,b   Assali, Abid ^a,b   Vaknin Assa, Hana ^a,b   Greenberg, Gabriel ^a,b   Lev, Eli I ^a,b   Bental, Tamir ^a,b  

^a RABIN MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE CORONARY SYNDROME; AGE; AGED; ANEMIA; ARTICLE; BARE METAL STENT; BARE METAL STENTING; CARDIAC PATIENT; CARDIOVASCULAR MORTALITY; COHORT ANALYSIS; CORONARY STENTING; DIABETES MELLITUS; DRUG ELUTING STENT; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE FAILURE; HEART LEFT VENTRICLE FUNCTION; HUMAN; KIDNEY INJURY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PERCUTANEOUS CORONARY INTERVENTION; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; PROGNOSTIC ASSESSMENT; RISK ASSESSMENT; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; CLINICAL TRIAL; INCIDENCE; ISRAEL; KAPLAN MEIER METHOD; MORTALITY; MULTICENTER STUDY; MYOCARDIAL INFARCTION; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RETROSPECTIVE STUDY; RISK FACTOR; SURVIVAL RATE; TIME; TRENDS;

ACUTE CORONARY SYNDROME; AGED; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; ISRAEL; KAPLAN-MEIER ESTIMATE; MALE; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE COMPLICATIONS; PROGNOSIS; RETROSPECTIVE STUDIES; RISK FACTORS; SURVIVAL RATE; TIME FACTORS;

EID: 84922566486     PISSN: 00029149     EISSN: 18791913     Source Type: Journal    
DOI: 10.1016/j.amjcard.2015.01.009     Document Type: Article

References (30)

1. 1 Ahmed, E., Al Suwaidi, J., El-Menyar, A., AlBinali, H.A., Singh, R., Gehani, A.A., Mortality trends in patients hospitalized with the initial acute myocardial infarction in a Middle Eastern country over 20 years. Cardiol Res Pract, 2014, 2014, 464323.
2. 2 Malenka, D.J., O'Connor, G.T., The Northern New England Cardiovascular Disease Study Group: a regional collaborative effort for continuous quality improvement in cardiovascular disease. Jt Comm J Qual Improv 10 (1998), 594–600.
3. 3 Antman, E.M., Cohen, M., Bernink, P., McCabe, C.H., Horacek, T., Papuchis, G., Mautner, B., Corbalan, R., Radley, D., Braunwald, E., The TIMI risk score for unstable angina∖non-ST elevation MI. JAMA 284 (2000), 835–842.
4. 4 Fox, K.A., Dabbous, O.H., Goldberg, R.J., Pieper, K.S., Eagle, K.A., Van de Werf, F., Avezum, A., Goodman, S.G., Flather, M.D., Anderson, F.A. Jr., Granger, C.B., Prediction of risk of death and myocardial infarction in the six months after presentation with acute coronary syndrome: prospective multinational observational study (GRACE). BMJ 333 (2006), 1091–1094.
5. 5 Kimmel, S.E., Berlin, J.A., Strom, B.L., Laskey, W.K., Development and validation of simplified predictive index for major complications in contemporary percutaneous transluminal coronary angioplasty practice. The Registry Committee of the Society for Cardiac Angiography and Interventions. J Am Coll Cardiol 26 (1995), 931–938.
6. 6 Lee, C.H., van Domburg, R.T., Hoye, A., Lemos, P.A., Tanabe, K., Smits, P.C., van der Giessen, W.J., de Feyter, P., Serruys, P.W., Predictors of survival after contemporary percutaneous coronary revascularization for acute myocardial infarction in the real world. J Invasive Cardiol 16 (2004), 627–631.
7. 7 O'Connor, G.T., Malenka, D.J., Quinton, H., Robb, J.F., Kellett, M.A. Jr., Shubrooks, S., Bradley, W.A., Hearne, M.J., Watkins, M.W., Wennberg, D.E., Hettleman, B., O'Rourke, D.J., McGrath, P.D., VerLee, P., Multivariate prediction of in-hospital mortality after percutaneous coronary interventions in 1994–1996. Northern New England Cardiovascular Disease Study Group. J Am Coll Cardiol 34 (1999), 681–691.
8. 8 Resnic, F.S., Ohno-Machado, L., Selwyn, A., Simon, D.I., Popma, J.J., Simplified risk score models accurately predict the risk of major in-hospital complications following percutaneous coronary intervention. Am J Cardiol 88 (2001), 5–9.
9. 9 Kornowski, R., Vaknin-Assa, H., Assali, A., Lev, E.I., Porter, A., Battler, A., Bental, T., A comparative analysis of major clinical outcomes with drug-eluting stents versus bare metal stents in male versus female patients. Eurointervention 7 (2012), 1051–1059.
10. 10 Bental, T., Assali, A., Vaknin-Assa, H., Lev, E.I., Brosh, D., Fuchs, S., Battler, A., Kornowski, R., Comparative analysis of major clinical outcomes using drug-eluting stents versus bare-metal stents in a large consecutive patient cohort. Catheter Cardiovasc Interv 76 (2010), 374–380.
11. 11 Codner, P., Bental, T., Assali, A., Vaknin-Assa, H., Lev, E., Kornowski, R., Long-term comparative analysis from an all-comer cohort of coronary patients treated using first- and second-generation drug-eluting stents. J Invasive Cardiol 26 (2014), 378–384.
12. 12 Assali, A., Vaduganathan, M., Vaknin-Assa, H., Lev, E.I., Brosh, D., Teplitsky, I., Bental, T., Battler, A., Kornowski, R., Comparison of late (3-year) registry data outcomes using bare metal versus drug-eluting stents for treating ST-segment elevation acute myocardial infarctions. Am J Cardiol 109 (2012), 1563–1568.
13. 13 Zaret, B.L., Wackers, F.J., Terrin, M.L., Forman, S.A., Williams, D.O., Knatterud, G.L., Braunwald, E., Value of radionuclide rest and exercise left ventricular ejection fraction in assessing survival of patients after thrombolytic therapy for acute myocardial infarction: results of Thrombolysis In Myocardial Infarction (TIMI) phase II study. The TIMI Study Group. J Am Collcardiol 26 (1995), 73–79.
14. 14 Nikolsky, E., Aymong, E.D., Halkin, A., Grines, C.L., Cox, D.A., Garcia, E., Mehran, R., Tcheng, J.E., Griffin, J.J., Guagliumi, G., Stuckey, T., Turco, M., Cohen, D.A., Negoita, M., Lansky, A.J., Stone, G.W., Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) trial. J Am Coll Cardiol 44 (2004), 547–553.
15. 15 National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 39:2 Suppl 1 (2002), S1–266.
16. 16 Beutler, E., Waalen, J., The definition of anemia: what is the lower limit of normal of the blood hemoglobin concentration?. Blood 107 (2006), 1747–1750.
17. 17 Go, A.S., Mozaffarian, D., Roger, V.L., Benjamin, E.J., Berry, J.D., Borden, W.B., Bravata, D.M., Dai, S., Ford, E.S., Fox, C.S., Franco, S., Fullerton, H.J., Gillespie, C., Hailpern, S.M., Heit, J.A., Howard, V.J., Huffman, M.D., Kissela, B.M., Kittner, S.J., Lackland, D.T., Lichtman, J.H., Lisabeth, L.D., Magid, D., Marcus, G.M., Marelli, A., Matchar, D.B., McGuire, D.K., Mohler, E.R., Moy, C.S., Mussolino, M.E., Nichol, G., Paynter, N.P., Schreiner, P.J., Sorlie, P.D., Stein, J., Turan, T.N., Virani, S., Wong, N.D., Woo, D., Turner, M.B., American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Executive summary: heart disease and stroke statistics—2013 update: a report from the American Heart Association. Circulation 127 (2013), 143–152.
18. 18 Spoon, D.B., Psaltis, P.J., Singh, M., Holmes, D.R., Gersh, B.K., Rihal, C.S., Lennon, R.J., Moussa, I.D., Simari, R.D., Gulati, R., Trends in cause of death after percutaneous coronary intervention. Circulation 129 (2014), 1286–1294.
19. 19 Ford, E.S., Ajani, U.A., Croft, J.B., Critchley, J.A., Labarthe, D.R., Kottke, T.E., Giles, W.H., Capewell, S., Explaining the decrease in U.S. deaths from coronary disease, 1980-2000. N Engl J Med 356 (2007), 2388–2398.
20. 20 Beghé, C., Wilson, A., Ershler, W.B., Prevalence and outcomes of anemia in geriatrics: a systematic review of the literature. Am J Med 116:Suppl 7A (2004), 3S–10S.
21. 21 Parikh, P.B., Jeremias, A., Naidu, S.S., Brener, S.J., Lima, F., Shlofmitz, R.A., Pappas, T., Gruberg, L., Impact of severity of renal dysfunction on determinants of in-hospital mortality among patients undergoing percutaneous coronary intervention. Catheter Cardiovasc Interv 80 (2012), 352–357.
22. 22 Peterson, E.D., Dai, D., DeLong, E.R., Brennan, J.M., Singh, M., Rao, S.V., Shaw, R.E., Roe, M.T., Ho, K.K., Klein, L.W., Krone, R.J., Weintraub, W.S., Brindis, R.G., Rumsfeld, J.S., Spertus, J.A., Contemporary mortality risk prediction for percutaneous coronary intervention. Results from 588,398 procedures in the national cardiovascular data registry. J Am Coll Cardiol 55 (2010), 1923–1932.
23. 23 Azar, R.R., Prpic, R., Ho, K.K., Kiernan, F.J., Shubrooks, S.J. Jr., Baim, D.S., Popma, J.J., Kuntz, R.E., Cohen, D.J., Impact of end-stage renal disease on clinical and angiographic outcomes after coronary stenting. Am J Cardiol 86 (2000), 485–489.
24. 24 Kunadian, V., Pugh, A., Zaman, A.G., Qiu, W., Percutaneous coronary intervention among patients with left ventricular systolic dysfunction: a review and meta-analysis of 19 clinical studies. Coron Artery Dis 23 (2012), 469–479.
25. 25 De Silva, K., Webb, I., Sicard, P., Lockie, T., Pattinson, S., Redwood, S., Perera, D., Does left ventricular function continue to influence mortality following contemporary percutaneous coronary intervention?. Coron Artery Dis 23 (2012), 155–161.
26. 26 Iqbal, J., Vergouwe, Y., Bourantas, C.V., Klaveren, D.V., Zhang, Y.J., Campos, C.M., García-García, H.M., Morel, M.A., Valgimigli, M., Windecker, S., Steyerberg, E.W., Serruys, P.W., Predicting 3-year mortality after percutaneous coronary intervention. Updated logistic clinical SYNTAX score based on patient-level data from 7 contemporary stent trials. J Am Coll Cardiol 7 (2014), 464–470.
27. 27 Tu, J.V., Bowen, J., Chiu, M., Ko, D.T., Austin, P.C., He, Y., Hopkins, R., Tarride, J.E., Blackhouse, G., Lazzam, C., Cohen, E.A., Goeree, R., Effectiveness and safety of drug-eluting stents in Ontario. N Engl J Med 357 (2007), 1393–1402.
28. 28 Marroquin, O.C., Selzer, F., Mulukutla, S.R., Williams, D.O., Vlachos, H.A., Wilensky, R.L., Tanguay, J.F., Holper, E.M., Abbott, J.D., Lee, J.S., Smith, C., Anderson, W.D., Kelsey, S.F., Kip, K.E., A comparison of bare-metal and drug-eluting stents for off-label indications. N Engl J Med 358 (2008), 342–352.
29. 29 Tamburino, C., Angiolillo, D.J., Capranzano, P., Dimopoulos, K., La Manna, A., Barbagallo, R., Tagliareni, F., Mangiafico, S., Guzman, L.A., Galassi, A.R., Bass, T.A., Complete versus incomplete revascularization in patients with multivessel disease undergoing percutaneous coronary intervention with drug-eluting stents. Catheter Cardiovasc Interv 72 (2008), 448–456.
30. 30 Kawaji, T., Shiomi, H., Morimoto, T., Tamura, T., Nishikawa, R., Yano, M., Tazaki, J., Imai, M., Saito, N., Makiyama, T., Shizuta, S., Ono, K., Kimura, T., Long-term efficacy and safety outcomes after unrestricted use of drug-eluting stents in patients with acute coronary syndrome. Circ J 78 (2014), 1628–1635.